Literature DB >> 15996135

Importance of animal models in schizophrenia research.

M van den Buuse1, B Garner, A Gogos, S Kusljic.   

Abstract

OBJECTIVE: This review aims to summarize the importance of animal models for research on psychiatric illnesses, particularly schizophrenia. METHOD AND
RESULTS: Several aspects of animal models are addressed, including animal experimentation ethics and theoretical considerations of different aspects of validity of animal models. A more specific discussion is included on two of the most widely used behavioural models, psychotropic drug-induced locomotor hyperactivity and prepulse inhibition, followed by comments on the difficulty of modelling negative symptoms of schizophrenia. Furthermore, we emphasize the impact of new developments in molecular biology and the generation of genetically modified mice, which have generated the concept of behavioural phenotyping.
CONCLUSIONS: Complex psychiatric illnesses, such as schizophrenia, cannot be exactly reproduced in species such as rats and mice. Nevertheless, by providing new information on the role of neurotransmitter systems and genes in behavioural function, animal 'models' can be an important tool in unravelling mechanisms involved in the symptoms and development of such illnesses, alongside approaches such as post-mortem studies, cognitive and psychophysiological studies, imaging and epidemiology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996135     DOI: 10.1080/j.1440-1614.2005.01626.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  23 in total

1.  Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.

Authors:  Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius Dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock
Journal:  Psychopharmacology (Berl)       Date:  2021-06-05       Impact factor: 4.530

2.  Preferential relocation of the N-methyl-D-aspartate receptor NR1 subunit in nucleus accumbens neurons that contain dopamine D1 receptors in rats showing an apomorphine-induced sensorimotor gating deficit.

Authors:  Y Hara; V M Pickel
Journal:  Neuroscience       Date:  2008-04-12       Impact factor: 3.590

3.  Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.

Authors:  Nigel C Jones; Maya Reddy; Paul Anderson; Michael R Salzberg; Terence J O'Brien; Didier Pinault
Journal:  Int J Neuropsychopharmacol       Date:  2011-06-09       Impact factor: 5.176

Review 4.  α2-Adrenoceptors are targets for antipsychotic drugs.

Authors:  Jan Brosda; Florian Jantschak; Heinz H Pertz
Journal:  Psychopharmacology (Berl)       Date:  2014-02-02       Impact factor: 4.530

Review 5.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

6.  Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia.

Authors:  Wendy Adams; Scott Ayton; Maarten van den Buuse
Journal:  Psychopharmacology (Berl)       Date:  2009-07-23       Impact factor: 4.530

7.  Dendritic distributions of dopamine D1 receptors in the rat nucleus accumbens are synergistically affected by startle-evoking auditory stimulation and apomorphine.

Authors:  Y Hara; V M Pickel
Journal:  Neuroscience       Date:  2007-05-09       Impact factor: 3.590

Review 8.  Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia.

Authors:  Christina A Wilson; James I Koenig
Journal:  Eur Neuropsychopharmacol       Date:  2013-11-26       Impact factor: 4.600

Review 9.  Developmental vitamin D deficiency and schizophrenia: the role of animal models.

Authors:  S A Schoenrock; L M Tarantino
Journal:  Genes Brain Behav       Date:  2016-01       Impact factor: 3.449

Review 10.  The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions.

Authors:  Alan Regenberg; Debra J H Mathews; David M Blass; Hilary Bok; Joseph T Coyle; Patrick Duggan; Ruth Faden; Julia Finkel; John D Gearhart; Argye Hillis; Ahmet Hoke; Richard Johnson; Michael Johnston; Jeffrey Kahn; Douglas Kerr; Patricia King; Joanne Kurtzberg; S Matthew Liao; John W McDonald; Guy McKhann; Karin B Nelson; Mahendra Rao; Andrew W Siegel; Kirby Smith; Davor Solter; Hongjun Song; Jeremy Sugarman; Angelo Vescovi; Wise Young; Henry T Greely; Richard J Traystman
Journal:  J Cereb Blood Flow Metab       Date:  2008-08-27       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.